What you need to know about ‘King Kong of weight-loss drugs’ - The drug, also known as tirzepatide, will be rolled out on the ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...

Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the ...

A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period.

As the NHS prepares to roll out Mounjaro for patients struggling with obesity, many eligible patients will be facing a ...

Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...

The latest Health Survey for England shows that 64% of adults were overweight or obese in 2022. However, Dr Kath McCullough, ...

However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...

Despite an estimated 3.4 million people in England meeting the eligibility criteria for Mounjaro, fewer than 10% will ...

The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body mass index (BMI) of more than 35 and at least one weight-related ...

Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight ...